Comments

October Surprise — 4 Comments

  1. I’m confident there won’t be any issues with the FDA authorizing non-efficacious vaccines. As you noted, though, safety is a whole different matter. There might be a big inclination to say, “safety is rarely in issue with vaccines and we haven’t seen anything worrisome over the past month or two, and it’s a matter of risk/benefit.”

    People over 65 are poorly represented in the sample population, and are probably more likely to experience serious “adverse events,” but will be among the priority groups to receive the vaccine. Another priority group of concern (to me) is pregnant women.

  2. Yes, it’s called Lancet + Putin. In the meantime, the world’s biggest culmination of over a decade of cutting edge US research is being put to applied use with over 5 different approaches and techniques in other 300 different manners. If that’s not a celebration of science and American ingenuity, I don’t know what is.

  3. And don’t forget your flu vaccine, to protect yourself from getting both at the same time! It’s considered one of the most effective vaccines we have. When I got mine, I also got a new, more effective shingles vaccine.

    • Good point, thanks Alice. We’re getting our flu shots next week; a bit of research turned up some locations offering drive-through, no-reservations innoculation. (We got the Shingrex recombinant shot last year.)

Leave a Reply

Your email address will not be published. Required fields are marked *

HTML tags allowed in your comment: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>